鬱を患っている高齢のプライマリケア患者における自殺念頭とうつ症状の軽減:ランダム化制御試験
Martha L Bruce1, Thomas R Ten Have, Charles F Reynolds
1Department of Psychiatry, Weill Medical College of Cornell University, White Plains, NY, USA.
JAMA
|March 5, 2004
まとめ
プライマリケアによる介入は,高齢者の自殺思考を著しく減少させました. このアプローチはうつ病の症状も改善し,高齢者の自殺予防におけるその役割を強調しました.
科学分野:
- ゲリアトリック・メディシン (老年医学)
- 精神科医は精神病を患っている.
- 公衆衛生は公衆衛生である.
背景:
- 高齢者の自殺率は非常に高く,高齢者の多くは死亡前に主治医に相談している.
- うつ病は,高齢者の自殺や自殺念頭の発症の主な危険因子です.
研究 の 目的:
- 高齢患者の自殺念頭とうつ病に対するプライマリケアベースの介入の影響を評価する.
主な方法:
- この研究では,20のプライマリケア・プラクティスでランダム化比較試験 (PROSPECT) を実施した.
- 参加者は,うつ病を患っている598人の高齢者を含め,年齢によって層分かれました.
- 介入グループは,通常のケアと比較して,個別化された治療ガイドラインとケアマネジメントを受けた.
主要な成果:
- 自殺考えは,通常のケアと比較して,介入グループで著しく早く減少した (P=.01).
- 自殺思考の解消は,介入患者の中でより迅速であり,8ヶ月でピークに達した (70.7%対43.9%).
- 介入した患者はより好ましいうつ病の経過を経験し,症状の軽減がより迅速でした.
結論:
- この介入は,プライマリーケア施設内の高齢者の多様なサンプルで,自殺念頭とうつ病を軽減する効果を示した.
- このアプローチは,人生の終わりに自殺のリスク要因を軽減する重要な予防戦略として機能します.
- この効果的な介入の持続性と普及には依然として課題があります.
関連する概念動画
Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Depressive Disorders: MDD and Dysthymia
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...


